Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Low valuations, looming deals: Why BB Biotech sees new cycle

In the latest 'Meet the Manager' video from Citywire, Dr Christian Koch explores how innovation, valuation and the firepower of big pharma could fuel a biotech recovery.
08.07.2025 - Christian Koch
Low valuations, looming deals: Why BB Biotech sees new cycle

Dies könnte Sie auch interessieren

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-Nr.: CH0038389992YTD: 23.47%Active Share: 79.47Anzahl Positionen: 22
    Lancierungsdatum: 16. November 1993